Champions Oncology
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CSBR and other ETFs, options, and stocks.About CSBR
Champions Oncology, Inc. engages in the development and sale of technology solutions and products to personalize the development and use of oncology drugs. Its technology platform, TumorGraft, is a novel approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice.
CEORobert Brainin
CEORobert Brainin
Employees213
Employees213
HeadquartersHackensack, New Jersey
HeadquartersHackensack, New Jersey
Founded1985
Founded1985
Employees213
Employees213
CSBR Key Statistics
Market cap94.30M
Market cap94.30M
Price-Earnings ratio40.56
Price-Earnings ratio40.56
Dividend yield—
Dividend yield—
Average volume8.76K
Average volume8.76K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$11.99
52 Week high$11.99
52 Week low$5.59
52 Week low$5.59
Stock Snapshot
As of today, Champions Oncology(CSBR) shares are valued at $6.79. The company's market cap stands at 94.3M, with a P/E ratio of 40.56.
On 2026-01-09, Champions Oncology(CSBR) stock opened at —, reached a high of —, and a low of —.
Champions Oncology(CSBR) shares are trading with a volume of 0, against a daily average of 8.76K.
During the past year, Champions Oncology(CSBR) stock moved between $5.59 at its lowest and $11.99 at its peak.
During the past year, Champions Oncology(CSBR) stock moved between $5.59 at its lowest and $11.99 at its peak.
CSBR News
The Motley Fool 2d
Champions Oncology Earnings TranscriptImage source: The Motley Fool. Wednesday, December 11, 2024 at 4:30 p.m. ET Call participants Chief Executive Officer — Ronnie Morris Chief Financial Officer —...
People also own
Based on the portfolios of people who own CSBR. This list is generated using Robinhood data, and it’s not a recommendation.